ArticleBMC cancer2021

The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial.

Xinxin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.